2005
DOI: 10.1002/0471142700.nc0805s20
|View full text |Cite
|
Sign up to set email alerts
|

A Fluorescent Intercalator Displacement Assay for Establishing DNA Binding Selectivity and Affinity

Abstract: A protocol for a fluorescent intercalator displacement (FID) assay useful for establishing DNA binding selectivity, affinity, stoichiometry, and binding site size, and for distinguishing modes of DNA binding is presented.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 44 publications
1
23
0
Order By: Relevance
“…Alternatively, the peptides may bind to DNA and compete with SYTOX green for binding sites, which will also lead to a decrease in, or quenching of fluorescence. A similar quenching effect was observed by Tse and colleagues with the fluorescent intercalator displacement assay [33]. In this assay a fluorescent dye (ethidium bromide) binds DNA, which leads to an increase in fluorescence.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…Alternatively, the peptides may bind to DNA and compete with SYTOX green for binding sites, which will also lead to a decrease in, or quenching of fluorescence. A similar quenching effect was observed by Tse and colleagues with the fluorescent intercalator displacement assay [33]. In this assay a fluorescent dye (ethidium bromide) binds DNA, which leads to an increase in fluorescence.…”
Section: Discussionsupporting
confidence: 75%
“…In this assay a fluorescent dye (ethidium bromide) binds DNA, which leads to an increase in fluorescence. The addition of a DNA binding compound displaces the bound ethidium bromide, and in turn leads to a decrease in fluorescence [33].…”
Section: Discussionmentioning
confidence: 99%
“…We first performed fluorescent intercalator displacement (FID) assays (23)(24)(25) to probe the interaction and binding preferences of (-)-lomaiviticins A-C (1-3) and (-)-kinamycin C (4) to duplex DNA (Fig. 2).…”
Section: Resultsmentioning
confidence: 99%
“…[1][2][3][4][5][6][7] Ever since the discovery of the structure of DNA in the 1950s, DNA has been a target for many therapeutic compounds. Several of these compounds have been found to bind to DNA while interfering with the activity of many vital enzymes and protein factors involved in DNA metabolism.…”
Section: Drug-dna Interactionsmentioning
confidence: 99%